These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29424490)

  • 1. Effects of 2 years of caloric restriction on oxidative status assessed by urinary F2-isoprostanes: The CALERIE 2 randomized clinical trial.
    Il'yasova D; Fontana L; Bhapkar M; Pieper CF; Spasojevic I; Redman LM; Das SK; Huffman KM; Kraus WE;
    Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29424490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary biomarkers of oxidative status in a clinical model of oxidative assault.
    Il'yasova D; Spasojevic I; Wang F; Tolun AA; Base K; Young SP; Marcom PK; Marks J; Mixon G; DiGiulio R; Millington DS
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1506-10. PubMed ID: 20501773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer's disease.
    Tuppo EE; Forman LJ; Spur BW; Chan-Ting RE; Chopra A; Cavalieri TA
    Brain Res Bull; 2001 Mar; 54(5):565-8. PubMed ID: 11397549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women and smokers have elevated urinary F(2)-isoprostane metabolites: a novel extraction and LC-MS methodology.
    Taylor AW; Bruno RS; Traber MG
    Lipids; 2008 Oct; 43(10):925-36. PubMed ID: 18751751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of matrix effects in the analysis of urinary F2-isoprostanes using novel multidimensional solid-phase extraction and LC-MS/MS.
    Zhang B; Saku K
    J Lipid Res; 2007 Mar; 48(3):733-44. PubMed ID: 17215547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of aerobic training on oxidative status in postsurgical non-small cell lung cancer patients: a pilot study.
    Jones LW; Eves ND; Spasojevic I; Wang F; Il'yasova D
    Lung Cancer; 2011 Apr; 72(1):45-51. PubMed ID: 20863590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort.
    Il'yasova D; Wang F; Spasojevic I; Base K; D'Agostino RB; Wagenknecht LE
    Obesity (Silver Spring); 2012 Sep; 20(9):1915-21. PubMed ID: 21959342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of F2-isoprostanes in urine by online solid phase extraction coupled to liquid chromatography with tandem mass spectrometry.
    Langhorst ML; Hastings MJ; Yokoyama WH; Hung SC; Cellar N; Kuppannan K; Young SA
    J Agric Food Chem; 2010 Jun; 58(11):6614-20. PubMed ID: 20476785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress in relation to diet and physical activity among premenopausal women.
    Anderson C; Milne GL; Sandler DP; Nichols HB
    Br J Nutr; 2016 Oct; 116(8):1416-1424. PubMed ID: 27725001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
    Liang Y; Wei P; Duke RW; Reaven PD; Harman SM; Cutler RG; Heward CB
    Free Radic Biol Med; 2003 Feb; 34(4):409-18. PubMed ID: 12566066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergence in urinary 8-iso-PGF(2alpha) (iPF(2alpha)-III, 15-F(2t)-IsoP) levels from gas chromatography-tandem mass spectrometry quantification after thin-layer chromatography and immunoaffinity column chromatography reveals heterogeneity of 8-iso-PGF(2alpha). Possible methodological, mechanistic and clinical implications.
    Tsikas D; Schwedhelm E; Suchy MT; Niemann J; Gutzki FM; Erpenbeck VJ; Hohlfeld JM; Surdacki A; Frölich JC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Sep; 794(2):237-55. PubMed ID: 12954376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cluster-randomized trial of water, sanitation, handwashing and nutritional interventions on stress and epigenetic programming.
    Lin A; Mertens AN; Rahman MZ; Tan ST; Il'yasova D; Spasojevic I; Ali S; Stewart CP; Fernald LCH; Kim L; Yan L; Meyer A; Karim MR; Shahriar S; Shuman G; Arnold BF; Hubbard AE; Famida SL; Akther S; Hossen MS; Mutsuddi P; Shoab AK; Shalev I; Rahman M; Unicomb L; Heaney CD; Kariger P; Colford JM; Luby SP; Granger DA
    Nat Commun; 2024 Apr; 15(1):3572. PubMed ID: 38670986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory factors of basal F(2)-isoprostane formation: population, age, gender and smoking habits in humans.
    Basu S; Helmersson J; Jarosinska D; Sällsten G; Mazzolai B; Barregård L
    Free Radic Res; 2009 Jan; 43(1):85-91. PubMed ID: 19085196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary F
    Melton CD; Luo R; Wong BJ; Spasojevic I; Wagenknecht LE; D'Agostino RB; Il'yasova D
    Ann Epidemiol; 2017 Jun; 27(6):391-396. PubMed ID: 28558917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin F(2alpha) metabolite and F(2)-isoprostane excretion rates in migraine.
    Helmersson J; Mattsson P; Basu S
    Clin Sci (Lond); 2002 Jan; 102(1):39-43. PubMed ID: 11749659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of exercise on oxidative stress: a 12-month randomized, controlled trial.
    Campbell PT; Gross MD; Potter JD; Schmitz KH; Duggan C; McTiernan A; Ulrich CM
    Med Sci Sports Exerc; 2010 Aug; 42(8):1448-53. PubMed ID: 20139793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum 8,12-iso-iPF2α-VI isoprostane marker of oxidative damage and cognition deficits in children with konzo.
    Makila-Mabe BG; Kikandau KJ; Sombo TM; Okitundu DL; Mwanza JC; Boivin MJ; Ngoyi MD; Muyembe JJ; Banea JP; Boss GR; Tshala-Katumbay D
    PLoS One; 2014; 9(9):e107191. PubMed ID: 25222616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic training reduces systemic oxidative stress in young women with elevated levels of F2-isoprostanes.
    Arikawa AY; Thomas W; Gross M; Smith A; Phipps WR; Kurzer MS; Schmitz KH
    Contemp Clin Trials; 2013 Mar; 34(2):212-7. PubMed ID: 23178737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of urine F2-isoprostane metabolite concentration in horses with colic and its potential use as a predictor for surgical intervention.
    Noschka E; Werre SR; Crisman MV; Thatcher CD; Milne GL; Dahlgren LA
    Equine Vet J Suppl; 2011 Aug; (39):34-41. PubMed ID: 21790752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific analysis in plasma and urine of 2,3-dinor-5, 6-dihydro-isoprostane F(2alpha)-III, a metabolite of isoprostane F(2alpha)-III and an oxidation product of gamma-linolenic acid.
    Burke A; Lawson JA; Meagher EA; Rokach J; FitzGerald GA
    J Biol Chem; 2000 Jan; 275(4):2499-504. PubMed ID: 10644705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.